Metraipolis › archive › dc_73edf9350d2c

Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study — Europe PMC PMID:42160591

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42160591
DOI
10.2337/dc25-2973
License (as archived)
solo-consultazione
Archived
2026-10-07T18:14:50.617Z
SHA-256 of the archived text
177b905cd31646bab945316f41d0a44fbfb2433d2cb521efbf357d93ddff9692
Stable URL of this page
https://metraipolis.com/documento/dc_73edf9350d2c

How to cite

Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study — Europe PMC PMID:42160591 — Europe PMC (en), https://europepmc.org/article/MED/42160591 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_73edf9350d2c (Metraipolis archive dc_73edf9350d2c, sha256 177b905cd31646bab945316f41d0a44fbfb2433d2cb521efbf357d93ddff9692)
BibTeX
@misc{dc73edf9350d2c,
  title = {Precision Prescribing of SGLT2 Inhibitors in Individuals With Type 2 Diabetes for Primary Prevention of Heart Failure: Model Development and Validation Study — Europe PMC PMID:42160591},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42160591},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_73edf9350d2c; sha256 177b905cd31646bab945316f41d0a44fbfb2433d2cb521efbf357d93ddff9692},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42160591. Agents can read the archived copy with the MCP tool read_document.